Matthew R. Henn - Chief Scientific Officer and EVP at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer and EVP
Stock Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Matthew R. Henn - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by Matthew R. Henn for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.53K $130K $17.30 Nov 15, 2025 Direct
Restricted Stock Units 878 $19K $0.81 Nov 15, 2025 Direct Common Stock
Stock Option (Right to Buy) 650K Feb 7, 2025 Direct Common Stock

Transactions reported by Matthew R. Henn for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.